FindTrial
Sign In

A comparative study to assess the safety and efficacy of Ambu Aura Gain versus I-Gel ( supraglottic airway devices) in adult patients under General Anaesthesia

A prospective randomized comparative study to assess the safety and efficacy of Ambu Aura Gain versus I-Gel in adult patients under General Anaesthesia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/09/057684
Enrollment
60
Registered
2023-09-15
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Group I: Insertion of I gel supraglottic device in adult patients undergoing elective surgeries under general anaesthesia. Control Intervention1: Group A: Insertion Of Ambu Aura Gain in

Sponsors

Department of Anaesthesia MMCRI Mysore
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All ASA grade I and II patients between 18-50 years of both sex. Elective surgeries under general anaesthesia with controlled ventilation. Body mass index 25-28 Kg/m2. Duration of surgery <2hrs.

Exclusion criteria

Exclusion criteria: Age 50 years. All ASA grade III and above. Mallampatti grade 3 and above. Emergency surgeries. Head and neck surgeries. Patients with decreaesed mouth opening. Patients with increased risk of aspiration. Patients with BMI >28 Kg/m2. Patients with abnormal or distorted anatomy of pharynx.

Design outcomes

Primary

MeasureTime frame
Oropharyngeal leak pressure Ease of Insertion & number of attempts. Time taken for insertion. Ease of insertion of Ryles tube . Fibreoptic bronchoscopic grading.Timepoint: 10 min 2 min—

Secondary

MeasureTime frame
Haemodynamic response, SpO2, EtCO2 Incidence of post operative complicationsTimepoint: 2 hrs 24hrs.—

Countries

India

Contacts

Public ContactDr Chaithanyashree R

Mysore Medical College and Research Institute.

vijayanagaraj@yahoo.co.in9886239622

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026